Literature DB >> 23988558

Evaluation of the Cryotech Vitrification Kit for bovine embryos.

C Gutnisky1, G M Alvarez, P D Cetica, G C Dalvit.   

Abstract

The purpose of this work was to assess commercially available Cryotech Vitrification Kit, in terms of survival, in vitro development and pregnancy rate for bovine embryos. Cumulus-oocyte complexes (COCs) were recovered from ovaries obtained from slaughtered cows and then matured in vitro for 22 h. COCs were fertilized by sex-sorted sperm in IVF-mSOF and cultured in IVC-mSOF for 7 days to the blastocyst stage. Blastocysts were vitrified with the Cryotech Vitrification Kit(®) and then either warmed to check viability or transferred to synchronized heifers. We observed 100% survival of the in vitro produced blastocysts and obtained the same pregnancy rate (46.8%) as that obtained using fresh in vitro produced blastocysts. We thus conclude that the Cryotech vitrification method is a valid alternative to other vitrification or slow-cooling methods in the bovine species and that it is ready for livestock production.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bovine embryo IVP; Bovine embryo vitrification; Cryotech; Vitrification

Mesh:

Year:  2013        PMID: 23988558     DOI: 10.1016/j.cryobiol.2013.08.006

Source DB:  PubMed          Journal:  Cryobiology        ISSN: 0011-2240            Impact factor:   2.487


  2 in total

1.  Healthy live births from transfer of low-mosaicism embryos after preimplantation genetic testing for aneuploidy.

Authors:  Chun-I Lee; En-Hui Cheng; Maw-Sheng Lee; Pin-Yao Lin; Yi-Chun Chen; Chien-Hong Chen; Lii-Shung Huang; Chun-Chia Huang; Tsung-Hsien Lee
Journal:  J Assist Reprod Genet       Date:  2020-07-04       Impact factor: 3.412

2.  Optimal timing of blastocyst vitrification after trophectoderm biopsy for preimplantation genetic screening.

Authors:  Hsiu-Hui Chen; Chun-Chia Huang; En-Hui Cheng; Tsung-Hsien Lee; Lee-Feng Chien; Maw-Sheng Lee
Journal:  PLoS One       Date:  2017-10-05       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.